US OptionsDetailed Quotes

DRIO241220P7500

Watchlist
  • 0.00
  • 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

No Data

Comments

    $DarioHealth (DRIO.US)$
    Dario Signs Four New Employer Contracts Across Full Product Suite
    DarioHealth (Nasdaq: DRIO) has secured four new self-insured employer contracts, expected to go live in Q1 2025. These contracts cover Dario's complete platform suite, with clients opting for multi-condition offerings rather than single-condition solutions. The company projects to achieve approximately 25 new client signings in 2024, representing a 35% growth in client base compared to 2023.
    These new ...
    $DarioHealth (DRIO.US)$
    Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
    DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals:
    Members with depression showed highe...
    $DarioHealth (DRIO.US)$ holding this for almost 4 months
    $DarioHealth (DRIO.US)$ Reuters· just
    DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
    $DarioHealth (DRIO.US)$
    Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
    New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...
Read more